Anthony Marfat

This inventor holds 62 USPTO granted patents and 9 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Pfizer Corporation, Lixte Biotechnology, Inc., Biopharma Works LLC. Active years: 1985-2024.

USPTO Granted Patents = 62 (Patent Applications = 9)

% Patents Active = 74.2

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 6 (Patent Applications = 12)

Average Co-Inventor Count = 2.1

ph-index = 13

Forward Citations = 599(Granted Patents)

Forward Citations (Not Self Cited) = 566(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Stonington, CT (US) (1999 - 2001)
Old Lyme, CT (US) (2018)
Mystic, CT (US) (1988 - 2022)
Groton, CT (US) (1985 - 2024)

Company Filing History:

Lixte Biotechnology, Inc.

Debiopharm International, S.a.

Biohaven Therapeutics Ltd.

patents

7. 1 out of 1

Krouzon Pharmaccuticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 1985-2024

Loading Chart...

Areas of Expertise:

Prodrugs

PDE4 Inhibitors

Antibacterial Agents

Oxabicycloheptane

Nicotinamide Derivatives

Beta-Lactamase Inhibitors

Indazole Derivatives

Pain Treatment

Hydroxamic Acid Derivatives

Therapeutically Active Compounds

Amine Prodrugs

Octahydrocyclopenta

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11866444 - Oxabicycloheptane prodrugs (2024-01-09),

2. 11236102 - Oxabicycloheptane prodrugs (2022-02-01),

3. 11083711 - Amine prodrugs of pharmaceutical compounds (2021-08-10),

4. 10618908 - Oxabicycloheptane prodrugs (2020-04-14),

5. 10435389 - Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2 (2019-10-08),

6. 10364252 - Oxabicycloheptane prodrugs (2019-07-30),

7. 10072018 - Compounds for treatment of pain (2018-09-11),

8. 10035813 - Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2018-07-31),

9. 9988394 - Oxabicycloheptane prodrugs (2018-06-05),

10. 9487531 - Compounds for treatment of pain (2016-11-08),

11. 9180123 - N-link hydroxamic acid derivatives useful as antibacterial agents (2015-11-10),

12. 9018384 - N-link hydroxamic acid derivatives useful as antibacterial agents (2015-04-28),

13. 8901105 - Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2014-12-02),

14. 8853258 - C-linked hydroxamic acid derivatives useful as antibacterial agents (2014-10-07),

15. 8846933 - N-link hydroxamic acid derivatives useful as antibacterial agents (2014-09-30),

Title: The Inventor Profile of Anthony Marfat

Introduction: Anthony Marfat, a talented inventor hailing from Mystic, CT (US), has made significant contributions to the field of innovation with his creative ideas and problem-solving skills.

Latest Patents: Anthony Marfat holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patent focuses on a groundbreaking technology that aims to revolutionize the way we interact with everyday devices.

Career Highlights: Throughout his career, Anthony Marfat has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His passion for creating practical and user-friendly inventions has led to the successful commercialization of several products.

Collaborations: Anthony Marfat has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the development and implementation of cutting-edge technologies.

Conclusion: In conclusion, Anthony Marfat's dedication to innovation and his relentless pursuit of excellence have established him as a respected figure in the world of inventors. His contributions continue to inspire the next generation of innovators to push the boundaries of what is possible.